Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Blaes AH et al. – The observations suggest that in this high risk population, EBV monitoring accompanied by preemptive therapy may reduce the risk of progression to life–threatening PTLD; further follow–up of this cohort and a larger multi–institutional prospective study of this preemptive strategy is warranted.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address